Open original FDA record ↗Recall record
- FDA identifier
- Z-1993-2013
- Company in FDA record
- Cardiogenesis Corporation
- FDA classification date
- Sep 11, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.
Source facts
- Action
- Cardiogenesis is responsible for the correction of all noncompliant products. CDRH understands that the corrective action plan (CAP), involving 2,437 Sologrip III handpieces and 61 PEARL 5.0 handpieces, consists of the following: 1. Notification to purchasers of the handpiece removal and replacement procedures, 2. Replace existing hospital inventory of handpieces with a redesigned handpiece CDRH approves the CAP subject to the following conditions: 1. Notification of all distributors and purchasers will be successfully implemented, and 2. Corrections will be made at no cost to the purchasers by October 1, 2013. For further questions please call (949) 420-1800.
- Initiated
- 2011-05-01
- Root cause
- Device Design
- Terminated
- 2014-09-15
- Distribution
- US Distribution
- Recall number
- Z-1993-2013
- Recall status
- Terminated
- CDRH record ID
- 121314
- FDA classified
- 2013-09-11
- Recall event number
- 66046